Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer.

Epidermal growth factor receptor (EGFR) has been the subject of much research since it was first described as a prognostic factor in breast cancer. The assay methods used and results obtained vary widely between studies. In this study 88 primary breast cancers were assayed for EGFR using a novel imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Newby, J. C., A'Hern, R. P., Leek, R. D., Smith, I. E., Harris, A. L., Dowsett, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033857/
https://www.ncbi.nlm.nih.gov/pubmed/7779717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033857/
https://www.ncbi.nlm.nih.gov/pubmed/7779717

Ejemplares similares